KalVista Pharmaceuticals (KALV) Equity Ratio: 2014-2024
Historic Equity Ratio for KalVista Pharmaceuticals (KALV) over the last 6 years, with Dec 2024 value amounting to 0.56.
- KalVista Pharmaceuticals' Equity Ratio was N/A to 0.56 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.56, marking a year-over-year change of. This contributed to the annual value of 0.88 for FY2024, which is N/A change from last year.
- As of Q4 2024, KalVista Pharmaceuticals' Equity Ratio stood at 0.56, which was down 33.08% from 0.83 recorded in Q4 2024.
- KalVista Pharmaceuticals' 5-year Equity Ratio high stood at 0.91 for Q2 2020, and its period low was 0.56 during Q4 2024.
- In the last 2 years, KalVista Pharmaceuticals' Equity Ratio had a median value of 0.83 in 2024 and averaged 0.80.
- Within the past 5 years, the most significant YoY rise in KalVista Pharmaceuticals' Equity Ratio was 10.53% (2020), while the steepest drop was 1.30% (2020).
- Quarterly analysis of 4 years shows KalVista Pharmaceuticals' Equity Ratio stood at 0.86 in 2020, then increased by 1.46% to 0.88 in 2021, then reached 0.82 in 2023, then climbed by 1.00% to 0.56 in 2024.
- Its Equity Ratio stands at 0.56 for Q4 2024, versus 0.83 for Q4 2024 and 0.86 for Q3 2024.